Does METHYLPHENIDATE Cause Reversible cerebral vasoconstriction syndrome? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Reversible cerebral vasoconstriction syndrome have been filed in association with METHYLPHENIDATE (Methylphenidate Hydrochloride). This represents 0.2% of all adverse event reports for METHYLPHENIDATE.
50
Reports of Reversible cerebral vasoconstriction syndrome with METHYLPHENIDATE
0.2%
of all METHYLPHENIDATE reports
0
Deaths
39
Hospitalizations
How Dangerous Is Reversible cerebral vasoconstriction syndrome From METHYLPHENIDATE?
Of the 50 reports, 39 (78.0%) required hospitalization.
Is Reversible cerebral vasoconstriction syndrome Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPHENIDATE. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPHENIDATE Cause?
Drug ineffective (4,924)
Off label use (4,842)
No adverse event (4,197)
Product quality issue (1,728)
Disturbance in attention (1,414)
Product substitution issue (1,408)
Anxiety (1,356)
Drug dose omission (1,330)
Headache (1,255)
Wrong technique in product usage process (1,250)
What Other Drugs Cause Reversible cerebral vasoconstriction syndrome?
ESCITALOPRAM OXALATE (165)
FLUOXETINE (154)
TACROLIMUS (127)
METHYLPREDNISOLONE (119)
SUMATRIPTAN (105)
VENLAFAXINE (105)
DULOXETINE (102)
SERTRALINE (102)
MYCOPHENOLATE MOFETIL (68)
CITALOPRAM HYDROBROMIDE (64)
Which METHYLPHENIDATE Alternatives Have Lower Reversible cerebral vasoconstriction syndrome Risk?
METHYLPHENIDATE vs METHYLPREDNISOLONE
METHYLPHENIDATE vs METHYLPREDNISOLONE ACEPONATE
METHYLPHENIDATE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPHENIDATE vs METILDIGOXIN
METHYLPHENIDATE vs METOCLOPRAMIDE